Monday, August 18, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Truist Securities Analyst Maintains Hold Rating on James River Group Holdings with Lowered Price Target

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Finances
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Truist Securities analyst Mark Hughes has decided to maintain a Hold rating on James River Group Holdings (NASDAQ: JRVR) but has made the bold move of lowering the price target from $15 to $11. This decision comes after Truist Financial also decided to decrease their price objective on James River Group from $15 to $11 while keeping a “hold” rating on the stock. The recent downgrade by Truist Securities is just one in a series of adjustments to the price target for James River Group, with analysts giving various reasons for the change. Despite these modifications, the average price target for James River Group Holdings Ltd still stands at $23.60, suggesting a potential 60.00% increase from the current price of $14.75.

JRVR Stock Price Drops 3.66% in Regular Trading Hours, Sees Uptick in After-Hours Trading

On March 1, 2024, JRVR stock experienced a significant drop in price, closing at $9.99, which represented a decrease of $0.38 or 3.66% from the previous market close. Despite the drop in price during regular trading hours, JRVR saw a slight uptick in after-hours trading, with the stock rising $0.49. This after-hours movement may indicate some level of investor confidence in the stock, potentially signaling a reversal in the downward trend that JRVR has been experiencing. Investors should conduct thorough research and consider their own risk tolerance before making any investment decisions. It is recommended to consult with a financial advisor or investment professional for personalized guidance tailored to individual financial goals and circumstances. Stay informed and stay vigilant in monitoring the performance of JRVR and other investments.

JRVR Stock Performance on March 1, 2024: Total Revenue Flat, Net Income Decline, and Earnings per Share Decrease

On March 1, 2024, JRVR stock experienced a mixed performance based on the financial data provided by CNN Money. The total revenue for the company was reported at $812.01 million for the past year, which remained flat compared to the previous year. However, there was a significant decrease of 6.56% in total revenue when compared to the last quarter, which was reported at $218.10 million.

The net income for JRVR was reported at -$107.68 million for the past year, showing a decrease of 447.67% compared to the previous year. On the other hand, the net income held flat since the last quarter, with a reported figure of $20.06 million. This indicates that the company was able to maintain its profitability in the short term despite the significant decrease in net income over the past year.

Earnings per share (EPS) for JRVR were reported at -$3.14 for the past year, showing a decrease of 632.29% compared to the previous year. The EPS further decreased by 1006.64% since the last quarter, with a reported figure of -$4.06. This indicates a significant decline in earnings per share for the company over both the short and long term.

Overall, the financial performance of JRVR on March 1, 2024, reflects a mixed picture. While the company was able to maintain its total revenue and net income in the short term, there were significant declines in both metrics over the past year. The decrease in earnings per share further highlights the challenges faced by JRVR in terms of profitability and financial performance. Investors and analysts will be closely monitoring the company’s future financial reports to assess its ability to improve its financial performance and drive growth in the coming quarters.

Tags: JRVR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Textile sustainable

Breaking Down the Environmental Impact of Clothing Production: What You Need to Know

Food Retailers Stock Bull Market

Analyst Sentiment and Price Targets Point to Bullish Outlook for Bath Body Works

Healthcare-IT-and-tech

TD Cowen Analyst Maintains Outperform Rating on Privia Health Group with Revised Price Target

Recommended

Insider Activity at Minerals Technologies Raises Questions about Stock Options

2 years ago
Pharmaceutical Markets and money

Gilead Sciences Inc Completes Waiting Period for Tender Offer for CymaBay Therapeutics Inc

1 year ago
Technology Blockchain Markets and money

Analyst Ratings and Price Targets for KLA NASDAQ KLAC

2 years ago
Finance_Credit

Trustco Bank Declares Quarterly Dividend of 36 Cents per Share

1 year ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • ETF
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE ADSK ALB AMD AMZN AVGO BA C CCL CELH COIN COST CRWD CTVA DELL DFS DIS DLR DLTR DWAC GM GRFS IBM INTC JPM KSS LLY META MSFT NFLX NVDA NVO ORCL PARA PLTR PLUG QCOM SMCI TGT TSLA UNH VZ
No Result
View All Result

Highlights

Danaher Stock: Market Experts Divided Amid Earnings Volatility

Institutional Investors Double Down on Ares Capital Despite Earnings Shortfall

Synopsys Stock: Diverging Signals Between Executives and Analysts

Biotech Stock Assembly Biosciences Gains Analyst Backing with $50 Price Target

Could Siemens Healthineers Emerge as the Dark Horse of Medical AI Innovation?

Geely Emerges as China’s Silent Contender in the EV Race

Trending

Axsome Stock
Stocks

Axsome Therapeutics Emerges as a High-Growth Contender in Neurological Drug Development

by Robert Sasse
August 18, 2025
0

Axsome Therapeutics is making waves in the biopharmaceutical sector with its groundbreaking treatments for some of neurology's...

Norfolk Southern Stock

Norfolk Southern Stock Gains Analyst Confidence Amid Operational Challenges

August 18, 2025
Newmont Mining Stock

Institutional Investors Divided on Newmont Mining as Gold Demand Surges

August 18, 2025
Danaher Stock

Danaher Stock: Market Experts Divided Amid Earnings Volatility

August 18, 2025
Ares Capital Stock

Institutional Investors Double Down on Ares Capital Despite Earnings Shortfall

August 18, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Axsome Therapeutics Emerges as a High-Growth Contender in Neurological Drug Development August 18, 2025
  • Norfolk Southern Stock Gains Analyst Confidence Amid Operational Challenges August 18, 2025
  • Institutional Investors Divided on Newmont Mining as Gold Demand Surges August 18, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • ETF
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com